Search

Your search keyword '"Eastwood, Kelly-Ann"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Eastwood, Kelly-Ann" Remove constraint Author: "Eastwood, Kelly-Ann"
131 results on '"Eastwood, Kelly-Ann"'

Search Results

4. The development of a core outcome set for studies of pregnant women with multimorbidity

6. Key outcomes for reporting in studies of pregnant women with multiple long-term conditions: a qualitative study

7. Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

8. Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

9. Clinical utility of 3D power Doppler ultrasound and maternal biomarkers in the prediction of pre-eclampsia in high-risk pregnancies

10. Added Value of Fetal Cardiac MRI in Rare Case of Suspected PAPVD with LPA Sling

12. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review

13. Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol

18. Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK

20. Association of pregnancy complications/risk factors with the development of future long-term health conditions in women: overarching protocol for umbrella reviews

21. Additional file 9 of Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

22. Additional file 3 of Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

23. Additional file 8 of Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

24. Additional file 1 of Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

27. Maternal and children’s outcomes for pregnant women with pre-existing multiple long-term conditions: a study protocol of an observational study in the United Kingdom

31. Additional file 2 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

32. Additional file 5 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

33. Additional file 12 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

34. Additional file 8 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

35. Additional file 7 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

36. Additional file 9 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

37. Additional file 4 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

38. Additional file 3 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

39. Additional file 6 of Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

40. Trends in maternal body mass index in Northern Ireland: a cross-sectional and longitudinal study: A cross-sectional and longitudinal study

42. Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a cross-sectional study

43. Protocol for the development of a core outcome set for studies of pregnant women with pre-existing multimorbidity

44. FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function

45. NOVEL MIRNAS AS TARGETS OF MESENCHYMAL STEM CELLS-BASED THERAPY FOR TREATMENT OF PREECLAMPSIA

46. FKBPL and SIRT-1, key angiogenesis proteins, are downregulated by diabetes in pregnancy

47. Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment

50. Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.

Catalog

Books, media, physical & digital resources